Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
463.91%
0%
463.91%
6 Months
581.82%
0%
581.82%
1 Year
525.0%
0%
525.0%
2 Years
410.2%
0%
410.2%
3 Years
328.57%
0%
328.57%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Vytrus Biotech SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
0.00%
EBIT Growth (5y)
0.00%
EBIT to Interest (avg)
0.82
Debt to EBITDA (avg)
0.73
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.51
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.42%
ROE (avg)
14.29%
Valuation key factors
Factor
Value
P/E Ratio
49
Industry P/E
Price to Book Value
10.81
EV to EBIT
45.04
EV to EBITDA
31.46
EV to Capital Employed
13.41
EV to Sales
13.63
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
29.77%
ROE (Latest)
21.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
5.00
3.70
35.14%
Operating Profit (PBDIT) excl Other Income
1.70
1.10
54.55%
Interest
0.10
0.10
Exceptional Items
-0.00
0.00
Consolidate Net Profit
1.00
0.50
100.00%
Operating Profit Margin (Excl OI)
180.10%
90.30%
8.98%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 35.14% vs 117.65% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 100.00% vs 150.00% in Dec 2023
About Vytrus Biotech SA 
Vytrus Biotech SA
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






